A U of M doctor is calling on people who have tested positive for COVID-19 and are showing early symptoms of infection to participate in two of the first trials of the malaria drug Hydroxychloroquine to treat coronavirus patients. Dr. David Boulware:
“And the question is can we give this preventive medicine to Hydroxychloroquine — can we give that to them to prevent them from actually get sick and break the chain of infection.”
The first trial will be comprised primarily of healthcare workers and others with a high risk of exposure to the virus, while the second will be open to the general public who have already tested positive for COVID-19. Hydroxychloroquine is being studied both as a way to prevent COVID-19 infection as well as a way to treat people who are already sick.